Marcus Jason L, Westerhaus Benjamin D, Fleming Jacob, Beall Douglas P, Sweeney Isis, Lewis Mark, Ghantiwala Vidur, Giuffrida Anthony
Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.
Interventional Spine & Pain Management, Cantor Spine Center at the Paley Orthopedic & Spine Institute, Fort Lauderdale, USA.
Cureus. 2024 Apr 15;16(4):e58333. doi: 10.7759/cureus.58333. eCollection 2024 Apr.
Anterior column pain refers to axial low back pain (LBP) originating from the intervertebral disc or vertebral endplates (discogenic or vertebrogenic pain). We sought to assess the safety and effectiveness of intradiscal steroid injection (IDSI) in diagnosing and treating patients with LBP arising from the anterior column.
This is a retrospective chart review of 66 patients who underwent 77 injections in an outpatient, private practice setting for the treatment of chronic lower back with history and physical exam findings indicating an origin within the anterior column and magnetic resonance imaging (MRI) findings of Modic changes associated with disc degeneration of grade 4 or above on the modified Pfirrmann scale. Patients reported pain as measured by the numerical rating scale (NRS) before the injection, at the time of their follow-up, and their maximum pain relief. The primary outcome was the change in NRS before and after the injections. The secondary outcome determined if the changes in the subjects' NRS met the minimal clinically important change (MCIC) criteria for LBP. We conducted a statistical analysis using a paired sample t-test.
There was a statistically significant difference between the pre-injection and follow-up NRS scores (p < 0.001) and a significant difference between pre-injection and maximum relief NRS scores (p < 0.001). Most subjects (55/77, 71.4%) met the MCIC to relieve their chronic LBP at the time of the follow-up evaluation.
For patients with chronic LBP and degenerative endplate changes, IDSIs provided these patients with significant short-term pain relief from pain arising from the anterior column.
前柱疼痛是指源于椎间盘或椎体终板的轴向腰痛(LBP)(椎间盘源性或椎体源性疼痛)。我们旨在评估椎间盘内注射类固醇(IDSI)在诊断和治疗前柱引起的腰痛患者中的安全性和有效性。
这是一项对66例患者的回顾性病历审查,这些患者在门诊私人诊所接受了77次注射,用于治疗慢性下腰痛,其病史和体格检查结果表明疼痛起源于前柱,且磁共振成像(MRI)结果显示在改良的Pfirrmann分级中为4级或以上的椎间盘退变相关的Modic改变。患者报告了注射前、随访时以及最大疼痛缓解程度时通过数字评分量表(NRS)测量的疼痛情况。主要结局是注射前后NRS的变化。次要结局是确定受试者NRS的变化是否符合LBP的最小临床重要变化(MCIC)标准。我们使用配对样本t检验进行了统计分析。
注射前和随访时的NRS评分之间存在统计学显著差异(p < 0.001),注射前和最大缓解时的NRS评分之间也存在显著差异(p < 0.001)。大多数受试者(55/77,71.4%)在随访评估时达到了MCIC以缓解其慢性LBP。
对于患有慢性LBP和退行性终板改变的患者,IDSI为这些患者提供了显著的短期疼痛缓解,缓解了前柱引起的疼痛。